Center for Physical Activity Research (CFAS)
Copenhagen, 2100, Denmark
NCT Number: NCT02257190
A single bout of Interval-Walking (IW) exercise is superior to energy-expenditure and time-duration matched Continuous Walking (CW) exercise upon improving glycemic control. The reason IW is superior is unknown.
This study will look into whether it is the larger peak intensity during IW or if it is the alternating exercise pattern that is responsible for the larger improvements seen.
Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions:
1. One hour of rest (Con) 2. One hour of classical interval walking (repeated cycles of 3 min of fast and 3 min of slow walking; IW3) 3. One hour of fast alternating interval walking (repeated cycles of 1 min of fast and 1 min of slow walking; IW1).
After the interventions subjects will undergo a standardized mixed meal tolerance test, with consecutive measurements of blood glucose, insulin and c-peptide.
Looking for future studies?
Notify Me30 year and older
All sexes
Interventional
Not applicable
Copenhagen, 2100, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One hour of rest.
Other names: No exercise
A one hour exercise bout with repeated cycles of 3 min of fast and 3 min of slow walking
Other names: 'Classical' interval walking, Interval walking - 3 min intervals
A one hour exercise bout with repeated cycles of 1 min of fast and 1 min of slow walking
Other names: 'Fast alternating' interval walking, Interval walking - 1 min intervals
Time frame: Within the first 4 hours after the interventions
Glycemic control will be measured after each intervention. Subjects will receive a standardized mixed meal tolerance test (MMTT), and blood glucose values will be obtained during the test.
Time frame: Within the first 4 hours after the interventions
Insulin and C-peptide will be measured during the MMTT
Time frame: Within the first 4 hours after the interventions
From the measurements og glucose and insulin during the MMTT, various indices of insulin sensitivity will be assessed
Rigshospitalet, Denmark
Other
Acronym: aIWS2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05108987
Behavior, Diabetes Mellitus
New Brunswick, New Jersey, United States
View Trial DetailsNCT03133156
Behavior, Body Weight
Boston, Massachusetts, United States
View Trial DetailsNCT03709966
Behavior, Diabetes Mellitus
Québec, Quebec, Canada
View Trial DetailsNCT03534687
Alzheimer Disease 10, Behavior
Ann Arbor, Michigan, United States
View Trial Details